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Introduction
Fusariotoxins which contaminate foods and feed worldwi-
de, are metabolites from several species of Fusarium genus,
soil fungi producing probably the most important quantity of
toxin in temperate north countries [16]. Zearalenone (ZEA),
one of the most widely distributed fusariotoxins, is common
in maize and maize products but also in soybeans and
various cereals grains, which represent a major part of
human food and animal feed. Crop contamination is often
inevitable and constitutes a potential risk for human and ani-
mal health [3]. Human and animal exposure comes mainly
from chronic contaminated food ingestion, but human expo-
sure can be direct via corn and cereals or indirect via animal
products.
ZEA causes oestrogenic syndrome in animals, resulting in
reproductive disorders and decreased fertility in a great num-
ber of species, with high variations of sensitivity. Female
pigs are considered as the most sensitive animal species
while poultry and ruminants show a lower responsiveness to
ZEA [7]. Absorption and metabolism are implicated in these
variations between species [6]. In particular, following oral
exposure in mammals, ZEA is metabolized in various tis-
sues, particularly in the liver, to the main metabolites identified
in vitro and in vivo: alpha zearalenol, α-ZOL and beta zeara-
lenol, ß-ZOL [13,14,25]. The rate of conversion and the ratio
α-ZOL/ß-ZOL shows species variations, and may account
for the species differences in the sensitivity to ZEA, as α-ZOL
shows a several-fold higher oestrogenic activity compared to
the parent compound ZEA whereas ß-ZOL has approximately
the same activity as ZEA [5,24]. Both these ZEA derivatives
have been described in naturally contaminated cereal grains
[10]. Further reduced forms, zearananone and zearalanols
(Figure 1) have also been identified in mammal urine
[12,27]. In poultry species, only little information is available
concerning ZEA metabolism whereas exposure is likely to
occur via feedstuffs, specially during force-feeding, corres-
ponding to a final average feed intake of approximately 10
kg of maize per duck [22].
SUMMARY
HPLC analysis of zearalenone (ZEA), zearalenols (α-ZOL and ß-ZOL)
and zearalanols (α-ZAL and ß-ZAL) was developed, in order to obtain a
sensitive and reproducible method to quantify ZEA and its reduced metabo-
lites in subcellular fractions of animal livers (S9 samples). 
Optimal in vitro metabolism was observed by incubating 5 mg S9 proteins
with 0.016 µmol. ZEA. Acetonitrile and diethylether/chloroform mixture
were compared for extraction, as well as different mobile phases and two
detection modes in HPLC analysis. Extracted samples were eluted with
water/acetonitrile (55:45, v/v) at a flow-rate of 1.0 ml/min-1, resulting in
well separated peaks between ZEA and the metabolites. The limits of detection
ranged from 0.5 to 2 ng/mg S9 proteins using UV, and from 0.04 to 4 ng/mg
S9 proteins, using fluorescence detection. Fluorescence showed a ten-fold
higher sensitivity than UV detection for ZEA and α-ZOL. Repeatability (10
assays) was 2.7% to 6.99% for zearalenols. Day-by-day coefficients of
variation for zearalenone and zeranols with UV detection were 3.3 to 8.5 %,
and 2.5 to 4.3 %, respectively. 
This analysis applied to S9 samples from ducks after 30 min of ZEA incu-
bation allowed to demonstrate that α-ZOL is the main reduced metabolite in
the duck. The present method is particularly adapted for studying in vitro
metabolism of ZEA and inter-species variations.
Keywords : Zearalenone, zearalenols, S9 liver fractions,
duck, metabolism, HPLC.
RÉSUMÉ
Analyse HPLC de la zéaralénone et de ses métabolites réduits dans
des fractions S9 de foie de canard
L’analyse HPLC de la zéaralénone (ZEA), des zéaralénols (α-ZOL et ß-ZOL)
et zéaralanols (α-ZAL et ß-ZAL) a été mise au point pour disposer d’une méthode
sensible et reproductible pour quantifier la ZEA et ses métabolites réduits dans
des fractions hépatiques subcellulaires. 
Le métabolisme in vitro optimal a été observé après incubation de 5 mg de
protéines de S9 avec 0.016 µmol de ZEA. L’acétonitrile et des mélanges diéthy-
léther/chlorofome ont été comparés pour l’extraction, ainsi que différentes pha-
ses mobiles et deux détecteurs pour l’analyse HPLC. Les échantillons extraits
élués avec un mélange eau/acétonitrile (55:45, v/v) à un débit de 1.0 ml/min-1,
ont conduit à des pics bien séparés entre ZEAet ses métabolites réduits. Les limi-
tes de détection ont été comprises entre 0.5 et 2 ng/mg de protéines avec détec-
tion UV, et entre 0.04 et 4 ng/mg de protéines avec détection fluorimétrique.
Cette dernière a montré une sensibilité dix fois supérieure à l’UV pour la ZEA et
l’α-ZOL. La répétabilité (10 répétitions) a été de 2.7% à 6.99% pour les zéara-
lénols. Les coefficients de variation jour-à-jour mesurés en détection UV ont été
de 3.3% à 8.5% et de 2.5% à 4.3% pour la zéaralénone et les zéranols, respecti-
vement.
Cette méthode appliquée à des S9 de canard incubés 30 minutes avec de la
ZEA a permis de montrer que l’α-ZOL constitue le principal métabolite réduit
chez le canard. La méthode décrite est particulièrement adaptée à l’étude du
métabolisme in vitro et aux variations interspécifiques.
Mots-clés : Zearalénone, zéaralénols, fraction S9 hépa-
tique, canard, métabolisme, HPLC.
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Various methods of analysis exist for monitoring the pre-
sence of ZEA in food and feed commodities [8] or for inves-
tigating biological fluids. Most quantitative methods applied
for determination of ZEA and derivatives include high-per-
formance liquid chromatography (HPLC) followed by fluo-
rescence detection [1,2,4,9,10,15,18,19,21,26], or UV detec-
tion [11, 23]. The aim of this work was to develop a simple,
sensitive, and reproducible HPLC method analysis to identify
and quantify zearalenone and its reduced metabolites in S9
fractions of duck-liver homogenates. First, optimal condi-
tions of incubation of ZEA for producing metabolites were
defined before extraction of ZEA and reduced metabolites,
followed by their separation and quantification. In the pre-
sent study, different extraction mixtures before HPLC, diffe-




Pure mycotoxin zearalenone (ZEA), cofactors NADH and
NADPH, reduced derivatives: ß-zearalenol (α-ZOL), α-zea-
ralenol (α-ZOL), zearalanone (ZAN), and α-zearalanol (ß-ZAL)
and ß-zearalanol (ß-ZAL) were purchased from Sigma
Chemical Co (Saint Quentin Fallavier, France). Stock solu-
tions were prepared in acetonitrile (5 mg/ml: ZEA, α and
ß-ZOL; 1 mg/ml: ZAN, α and ß-ZAL); after sonication (15
minutes) they were stored in the dark at -20°C. The follo-
wing chemicals were used for the preparation of hepatic frac-
tions: KH2PO4 and K2HPO4 from Prolabo, trisacetate and
buthylhydroxytoluene (BHT) from Sigma, KCl, EDTA
2H2O, NaOH, HCL from Merck. Dye reagent concentrate
(Biorad) and bovine serum albumin (BSA, 100 µg/ml) were
used for the dosage of total proteins. Distilled deionized
water and HPLC grade solvents were used. 
SAMPLES PREPARATION 
Subcellular fractions
Two mallard ducks were used for the preparation of liver
fractions (Pygavi, Muret, France, 4-weeks old). They had
free access to complete diet (Aliso, Auch, France). They
were killed according to the ethical recommendations and in
accordance with European Guidelines for the care and use of
animals for research purposes. The livers were removed and
all the subsequent operations were carried out at 0-4°C.
The subcellular fractions were prepared in duplicate for
each animal. The livers were cut into small pieces, and 8 g
samples were homogenized in 15 ml of ice-cold buffer :
potassium phosphate pH 7.4 buffer (0.1M KH2PO4, 0.1M
K2HPO4) and 0.1M Tris acetate, 0.1M KCl, 1 mM EDTA
and 0.02 mM BHT (40 mg/10 ml ethanol) in a glass Potter
homogenizer with a Teflon pestle. After filtration, the homo-
genate was centrifuged at 9000xg for 30 min in a TGA-65
Kontron ultracentrifuge. The supernatant, as 1-ml aliquots,
was stored at -80°C until use. 
IN VITRO METABOLISM OF ZEA AND EXTRACTION
Protein concentration in the subcellular fraction was deter-
mined by the method of Bradford, using BSA as standard
and the kit Biorad (Microassay procedure). For each animal
sample, proteins were dosed in triplicate, and repeated for
four days, to estimate reproducibility and repeatability of the
colorimetric assay. The mean of these measurements was
used for estimating S9 volume required for incubations.
First, incubation conditions were tested, to ensure that acti-
vities were measured under linear conditions with respect to
substrate concentrations.
Preliminary experiments were conducted in duck fractions
to ensure linearity without saturation of enzyme activities:
2.5, 5 and 10 mg of duck S9 proteins on one part, in a 1ml-
incubation volume. On another part, 50 µL from 25, 50, 100
or 200 µg/ml ZEA corresponding to 4, 8, 16 and 30 µM
respectively of final ZEA, were incubated with 5 mg S9 pro-
teins. After these preliminary assays, 5 mg of proteins from
the subcellular fractions and 100 µg/ml ZEA (50 µL), were
incubated in 1ml phosphate buffer with co-factors in excess:
2.4 µmol of NADH and NADPH. The temperature of incu-
bation was adapted to poultry metabolism, and maintened at
40°C for 30 min. All samples were extracted twice with 10
ml of extraction solution (diethylether/chloroform, 3:1, v/v)
for 30 min and centrifuged at 2000 g for 10 min. Two different
solvents were tested as extraction solvents: acetonitrile and
diethylether/chloroform mixtures. The organic phases were
collected, evaporated to dryness under nitrogen (50°C, 30
min), and residues were dissolved in 100 µL of acetonitrile,
and sonicated.
Extraction control samples were prepared for each animal
and each analysis (ZEA without incubation) and serve to
estimate global rate of ZEA extraction of the assays.
HPLC ASSAY OF ZEA, ZOLS, AND ZALS
The HPLC apparatus include an isocratic pump (model
2200, ICS) and a Rheodyne injection loop of 20 µL (ICS). The
injection followed immediately sonication of the reconstituted
extract. Elution was through a Prontosil column 120-5 C18 H
(250x4 mm, 5 µm particle size; Bischoff) with water/acetoni-
tile (55:45, v/v) at a 1ml/mn flow-rate. Various solvents were
tested to elute ZEA, ZOLS and ZALS mixtures, to obtain well
separated peaks: MeOH:H2O (70:30 v/v and 65:35 v/v),
ACN:H2O (60:40; 50:50 and 45:55), MeOH:ACN:H20
(22:35:43 v/v/v), MeOH:ACH:H2O:CH3COOH (22:35:43:0.5).
The mobile phase was prepared and degased before each
assay. The column was kept at 20°C, and was connected to a
guard column (C18, 5µm, Prontosil). Two detectors were
used: a UV detector (Spectra Focus), at 235 nm, and a fluo-
rescence detector (Shimadzu, RF-10AXL) at excitation wave-
length λexc 274 nm/emission wavelength, λem 440 nm.
Chromatograms were integrated with ANAPIC3 software.
The dosage method of the following reduced metabolites
was validated: ß-zearalenol (ß-ZOL), α-zearalenol (α-ZOL),
zearalanone (ZAN), α-zearalanol (α-ZAL) and ß- zearalanol
(ß-ZAL). Standard solutions of each compound in acetonitrile
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(0.004 to 50 µg/ml: 6 concentrations for ZEA (0.097, 0.391,
1.563, 6.25, 25 and 50 µg l-1), 9 concentrations for the meta-
bolites: 0.097, 0.195, 0.391, 0.781, 1.563, 3.125, 6.25, 12,5
and 25 µg l-1) were analysed in triplicate and calibration curves
were obtained. Detection and quantification limits were defi-
ned as signal to noise ratio equal or superior to 3 and 10,
respectively. A mixture of the standards were extracted and
injected in parallel to the samples to serve as controls.
Results
DEVELOPMENT OF THE HPLC METHOD
The whole UV spectrum from 190 to 320 nm of each meta-
bolite (6.25µg/ml in acetonitrile) showed maximum absorbance
at 235 nm for zearalenone and zearalenols, and at 218 nm for
zearalanone and zearalanols. The HPLC method was adapted
from several studies [2,4,9,15,18,19,21,26].
We tested various solvent mixtures as mobile phase in order
to obtain a retention time for zearalenone well after the reduced
metabolites but not too long (less than 30 minutes) and to
obtain a high peak. The higher peak resolution was observed in
water/acetonitile (55:45, v/v) with a retention time of 16-18
minutes for zearalenone (table I). In our chromatographic
conditions, zearalenone (ZEA), α-zearalenol (α-ZOL) and ß-
zearalenol (ß-ZOL) showed well separated peaks at retention
times of 16-18 minutes, 9-10 minutes, and 6-7 minutes respec-
tively, using UV-detection at 235 nm or fluorescence detection.
For this detection mode, we tested two excitation wavelengths
with emission wavelength λem 440 nm: λexc 236 nm and λexc
274 nm, and we choose this latter λexc., because of higher
signals, in accordance with other studies [4,10,15,26].
Zearalanone, α-zearalanol and ß-zearalanol showed also well
separated peaks using UV-detection at 218 nm or fluorescence
detection. Elution times were of 17-18 minutes, 6-7 minutes
and 9-10 minutes respectively (data not shown). 
Calibration curves and limits of detection are summarized
in table II. R2 of 0.9992, 0.9995 and 0.9999 for ZEA, α-ZOL
and ß-ZOL respectively were observed. The limits of detec-
tion using UV were 0.5 to 2 ng/mg proteins and ranged from
0.04 ng to 4 ng/mg with fluorescence detection for all the six
metabolites tested. The highest sensitivity was observed for
the zearalenols, which are described as activated metabolites,
key factors in zearalenone toxicity. For ZEA and α-ZOL,
fluorescence detection was ten fold more sensitive than UV
one, in agreement with published results [2]. For ß-ZOL,
fluorescence detection was less sensitive than UV detection,
because of less fluorescent properties of this metabolite than
ZEA and α-ZOL [1,15]. Our results demonstrate that both
zearalenols metabolites can be quantified by the two studied
detection modes. We preferred UV detection at two wave-
length to differenciate ZOLs and ZALs showing similar
retention times. Our HPLC assay is characterized by simpli-
city compared to other assays requiring more sophisticated
materials to quantify all zearalenone reduced metabolites, for
example mass spectrometric detection [26].
Repeatability, estimated by ten separate measurements of
the same sample was less than 5% for reduced metabolites
but 12.5% for ZEA. Reproducibility (day-by-day variation,
3 assays per day, 3 days) was measured for zearalenols and
zearalanone with UV detection, showing variation coeffi-
cients of 2.5 to 4.3% and of 3.3 to 8.5% respectively. The
HPLC method analysis is reliable and reproducible, as all the
variation coefficients of reduced metabolites were less than
5%. For ZEA, we observed a day-by-day CV of 8.5 % and CV
for response factor of 12.66 % (table II), which is consistent
with previous published results for this toxin [2]. Considering
the main objective of this work was quantifying reduced
metabolites, we have considered this result acceptable. 
FIGURE 1: Structures of zearalenone (A), and its reduced metabolites (B
to F): zearalenols, α-zearalenol (B) and ß-zearalenol (C), and zeara-
lanone (F), α-zearalanol (D) and ß-zearalanol (E).
FIGURE 2: Incubations of 5 mg duck S9 proteins/ml with 50 µl of ZEA
concentrations of 25, 50, 100 and 200 µg/ml, at 40°C, for 30 minu-
tes. The reduced metabolites of zearalenone (ZEA) are represented
according to the conditions of incubations: α-zearalenol (open trian-
gles), and ß-zearalenol (squares).
FIGURE 3: Incubations with 2.5 mg, 5 mg and 10 mg duck S9 proteins
with 190 µg/ml of ZEA at 40°C, for 30 minutes. The reduced meta-
bolites of zearalenone (ZEA) are represented according to the condi-
tions of incubations: α-zearalenol (open triangles), and ß-zearalenol
(squares).
FIGURE 4: A: Chromatogram representati-
ve of duck samples (S9 fractions incu-
bated with 16 µM zearalenone for 30
minutes); B: mixture of standards 1 =
ß-zearalenol; 2 = α-zearalenol; 3=zea-
ralenone; [1]=[2]=[3]= 30 µg/ml
C18 250*4 mm, 5µm column, mobile
phase acetonitrile/H20 45/55 v/v,
injected volume: 20 µL; 1 ml/mn flow
rate; range 0.1 AUFS; UV detection at
235nm. 
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EXTRACTION PROCEDURE AND HPLC ANALYSIS IN
LIVER SUBCELLULAR FRACTIONS (S9) AFTER INCU-
BATION OF ZEA
We adapted the incubation and extraction procedure from
Pompa et al. [17]. The results of experiments to test incubation
conditions are shown in figures 2 and 3. A volume corres-
ponding to 5mg S9 proteins and ZEA concentration of
100µg/ml (final concentration of 16 µM) were selected for
incubations, in order to observe a linear production of both
α-ZOL and ß-ZOL without saturation. The extraction mixture
diethylether/chloroform 3:1, v/v was chosen because of
higher extraction rate and higher reproducibility of signals
compared to acetronitrile. The extraction with acetonitrile
was rejected because of very slow evaporation and of lower
solubilization of metabolites compared to diethylether/chloro-
form. Using diethylether/chloroform 3:1, the extraction rate
was of 82 % ± 6 % for ZEA, consistent with the results of
previous works [1,4,15,23].
Metabolites were identified by comparison of retention
times with those of standards and quantified by their peak area
ratio with standards. Using the UV-detection wavelengths of
218 nm and 235 nm, neither zearalanone nor zearalanols were
found in any of the S9 samples. In the ducks S9 fractions
(Figure 4), metabolized zearalenone accounted for about one
half of the extracted fraction after 30 min of incubation
(50±3%, n=4) , α-ZOL and ß-ZOL representing 39 %
(39±5%) and 11% (11±3%) respectively. Non metabolized
zearalenone represented the remainder of the fraction. These
are the first published results concerning the metabolism of
ZEA in the mallard duck. These in vitro results show that
ducks produce mainly α-ZOL, as described in mammals.  
Conclusion
The method presented here is particularly adapted for studying
zearalenone metabolism, showing sensitivity, reproducibility
and repeatability for the main recognized reduced meta-
bolites: zearalenols. The performance of UV detection
appears to be sufficient and adapted for in vitro metabolism
studies. For kinetic and residues studies, fluorescence detection,
Zearalenone in acetonitrile, 6.25 µg/mL; UV detection (λmax 235 nm), injected volume: 20 µL; 1 ml/mn flow rate; range 0.1 AUFS.
Mobile phase composition Ratio v/v RT (minutes) H
CH3OH/H2O 70/30 10.437 14396
65/35 23.187 7117
CH3CN/H2O 60/40 6.566 17033
50/50 12.075 9 142
45/55 18.533 13170
CH3OH/ CH3CN/H2O 22-35-43 15.870 14883
CH3OH/CH3CN/H2O/CH3COOH 22-35-43-0.5 15.25 12300
CH3CN/H2O/CH3COOH 22-35-43-0.5 15.770 14523
TABLE 1: Influence of the mobile phase on the retention time of zearalenone (RT) and on the area of
the peak (H). 
* CV = coefficient of variation 
Elution with acetonitrile/H20 45/55 v/v; 1ml/min flow-rate; injected volume: 20 µL; column C18 250*4mm, 5µm; UV detection (235 or 218 nm),
or fluorescence detection (“fluo”: λexc 274 nm/ λem 440 nm).
Detection Linearity range (ng) CV* (%) R2 Detection limit 
(ng/mg proteins)
Zearalenone UV 235 nm 25-1000 12.6 0.999 1
(ZEA) Fluo. 0.3-150 2.7 1.000 0.15
α-zeaealenol UV 235 nm 1-5000 4.3 0.999 0.5
(α-ZOL) Fluo. 4-75 4.4 0.999 0.04
ß-zeaealenol UV 235 nm 25-500 6.9 0.999 0.5
(ß -ZOL) Fluo. 9-300 3.8 0.999 0.3
Zearalanone UV 218 nm 1-500 4.1 0.999 0.5
Fluo. 8-62 3.4 0.999 4
α-zeaealanol UV 218 nm 62.5-500 1.9 1.000 2
Fluo. 16-62 12.6 0.991 2
ß-zeaealanol UV 218 nm 5-500 4.6 0.995 0.5
Fluo. 8-126 4.3 0.999 4
TABLE 2: Validation of HPLC assay 
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showing ten-fold higher sensitivity for alpha-zearalenol and
zearalenone, will be prefered. The present results tend to
show that zearalanols are not produced in the duck, as it is
the case in most of mammalian species, notably rat or pig.
These results have to be confirmed in other poultry species. 
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